Submitted by Anonymous (not verified) on 27 November 2023 - 14:52
Human medicines European public assessment report (EPAR): Triumeq, abacavir sulfate / dolutegravir sodium / lamivudine, HIV Infections, Date of authorisation: 31/08/2014, Revision: 32, Status: Authorised
Source: